Related Experiment Video
Updated: May 27, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
IFNβ drives ferroptosis through elevating TRIM22 and promotes the cytotoxicity of RSL3
Huiyue Dong1,2, Ling Zhu1,2, Jingjing Sun1,3
1Fujian Provincial Key Laboratory of Transplant Biology, Dongfang Hospital (the 900th Hospital of Joint Logistic Support Force), Xiamen University, Fuzhou, China.
Background:
Cyclic GMP-AMP synthase (cGAS)-stimulator-of-interferon genes (STING) pathway is a cytosolic DNA sensor system. The production of this pathway, interferon-β (IFNβ), could suppress the growth of tumor cells, yet it is unclear whether ferroptosis is involved in IFNβ-induced cell death.
Methods:
The effects of IFNβ on ferroptosis were analyzed in HT1080, 4T1, HCT116 and 786-O cells. HT1080 and 4T1 cells treated with IFNβ were subjected to RNA-Seq analysis. STAT1, STAT3, TRIM21, and TRIM22 were silenced by siRNAs to examine their effects on IFNβ-induced ferroptosis. The cGAS-STING signaling pathway-activated mice were used to evaluate the effects of IFNβ on ferroptosis in vivo. HT1080 cells, three-dimensional (3D) spheroids, and the xenograft mouse models were treated with IFNβ, RSL3, or IFNβ combination with RSL3 to analyze whether IFNβ enhances RSL3-induced ferroptosis.
Results:
Here, we found that IFNβ could promote intracellular Fe2+ and lipid peroxidation levels, and decrease GSH levels in tumor cells. RNA sequencing data revealed that IFNβ induced a transcriptomic disturbance in ferroptosis-related genes. Knockdown of tripartite motif-containing 22 (TRIM22) suppressed the levels of intracellular Fe2+ and lipid ROS. It also reduced heme oxygenase (HMOX1) protein levels and increased ferroptosis suppressor protein 1 (FSP1) levels in HT1080 cells treated with IFNβ. Furthermore, our results illustrated that IFNβ enhanced the RAS-selective lethal 3 (RSL3)-induced ferroptosis and the inhibitory effect of RSL3 on GPX4. Meanwhile, compared to the groups treated with either IFNβ or RSL3 alone, the combination treatment of IFNβ and RSL3 significantly inhibited the growth of HT1080 three-dimensional (3D) spheroids and tumor in a mouse xenograft model.
Conclusions:
Our work reveals a role for IFNβ in promoting ferroptosis and provides evidence that IFNβ could be used with RSL3 to increase cytotoxic effects in tumor cells.
Insights
Interferon-beta (IFNβ) promotes ferroptosis, a form of cell death, by increasing iron and lipid peroxidation in tumor cells. Combining IFNβ with RSL3 enhances anti-tumor effects, suggesting a potential therapeutic strategy.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- The cyclic GMP-AMP synthase (cGAS)-stimulator-of-interferon genes (STING) pathway senses cytosolic DNA.
- Interferon-beta (IFNβ), a product of this pathway, can suppress tumor growth.
- The role of ferroptosis in IFNβ-induced cell death remained unclear.
Purpose of the Study:
- To investigate the effects of IFNβ on ferroptosis in tumor cells.
- To elucidate the molecular mechanisms underlying IFNβ-induced ferroptosis.
- To evaluate the potential of combining IFNβ with ferroptosis-inducing agents for cancer therapy.
Main Methods:
- IFNβ treatment and ferroptosis analysis in multiple cancer cell lines (HT1080, 4T1, HCT116, 786-O).
- RNA-sequencing to analyze transcriptomic changes induced by IFNβ.
- Gene silencing (siRNA) of STAT1, STAT3, TRIM21, and TRIM22 to assess their roles.
- In vivo studies using cGAS-STING pathway-activated mice and xenograft models.
- Combination therapy studies with IFNβ and RSL3 (a ferroptosis inducer).
Main Results:
- IFNβ increased intracellular iron (Fe²⁺) and lipid peroxidation, while decreasing glutathione (GSH) levels in tumor cells.
- RNA-seq revealed IFNβ-induced alterations in ferroptosis-related gene expression.
- Knockdown of tripartite motif-containing 22 (TRIM22) reversed IFNβ-induced changes in Fe²⁺, lipid ROS, heme oxygenase (HMOX1), and ferroptosis suppressor protein 1 (FSP1).
- IFNβ enhanced RSL3-induced ferroptosis and inhibited GPX4 activity.
- Combined IFNβ and RSL3 treatment significantly inhibited tumor growth in 3D spheroids and xenograft models.
Conclusions:
- IFNβ actively promotes ferroptosis in tumor cells.
- TRIM22 plays a crucial role in mediating IFNβ-induced ferroptosis.
- The combination of IFNβ and RSL3 demonstrates enhanced anti-tumor efficacy, suggesting a promising therapeutic strategy.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Regulation of the Unfolded Protein Response
The Extrinsic Apoptotic Pathway

